A phase I/II study of cancer peptide vaccine S-288310 in patients with advanced urothelial carcinoma of the bladder.
Obara W, Eto M, Mimata H, Kohri K, Mitsuhata N, Miura I, Shuin T, Miki T, Koie T, Fujimoto H, Minami K, Enomoto Y, Nasu T, Yoshida T, Fuse H, Hara I, Kawaguchi K, Arimura A, Fujioka T.
Obara W, et al. Among authors: arimura a.
Ann Oncol. 2017 Apr 1;28(4):798-803. doi: 10.1093/annonc/mdw675.
Ann Oncol. 2017.
PMID: 27998971
Free article.
Clinical Trial.